Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4168576
Max Phase: Preclinical
Molecular Formula: C46H68N8O7
Molecular Weight: 845.10
Molecule Type: Small molecule
Associated Items:
ID: ALA4168576
Max Phase: Preclinical
Molecular Formula: C46H68N8O7
Molecular Weight: 845.10
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)C[C@@H](N)Cc2ccccc2)CCCCCCC[C@@H](C(=O)N(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC1=O
Standard InChI: InChI=1S/C46H68N8O7/c1-30(2)26-37-42(57)48-31(3)45(60)54-25-17-24-39(54)44(59)51-36(46(61)53(4)5)23-16-8-6-7-15-22-35(41(56)52-37)50-43(58)38(28-33-20-13-10-14-21-33)49-40(55)29-34(47)27-32-18-11-9-12-19-32/h9-14,18-21,30-31,34-39H,6-8,15-17,22-29,47H2,1-5H3,(H,48,57)(H,49,55)(H,50,58)(H,51,59)(H,52,56)/t31-,34-,35-,36-,37-,38-,39-/m0/s1
Standard InChI Key: HOMMWZVRTXVATL-QOOAZBNCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 845.10 | Molecular Weight (Monoisotopic): 844.5211 | AlogP: 2.50 | #Rotatable Bonds: 12 |
Polar Surface Area: 212.14 | Molecular Species: BASE | HBA: 8 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.84 | CX Basic pKa: 8.94 | CX LogP: 2.68 | CX LogD: 1.14 |
Aromatic Rings: 2 | Heavy Atoms: 61 | QED Weighted: 0.19 | Np Likeness Score: 0.32 |
1. Chen X, Liu L, Chen Y, Yang Y, Yang CY, Guo T, Lei M, Sun H, Wang S.. (2018) Cyclic Peptidic Mimetics of Apollo Peptides Targeting Telomeric Repeat Binding Factor 2 (TRF2) and Apollo Interaction., 9 (5): [PMID:29795768] [10.1021/acsmedchemlett.8b00152] |
2. Chen X,Dong Y,Guo T,Yang CY,Chen Y,Sun H. (2020) N-terminal modified cyclopeptidic mimetics of Apollo as inhibitors of TRF2., 30 (21.0): [PMID:32871539] [10.1016/j.bmcl.2020.127401] |
Source(1):